These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3943186)

  • 1. Homogeneous, liposome-based assay for total complement activity in serum.
    Bowden DW; Rising M; Akots G; Myles A; Broeze RJ
    Clin Chem; 1986 Feb; 32(2):275-8. PubMed ID: 3943186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid, homogeneous phase, liposome-based assays for total complement activity.
    Akots G; Braman JC; Broeze RJ; Bowden DW
    Complement; 1984; 1(3):125-33. PubMed ID: 6399881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated homogeneous liposome-based assay system for total complement activity.
    Yamamoto S; Kubotsu K; Kida M; Kondo K; Matsuura S; Uchiyama S; Yonekawa O; Kanno T
    Clin Chem; 1995 Apr; 41(4):586-90. PubMed ID: 7720251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A kinetic nephelometric method for the assay of serum C3 and C4.
    White RM; Buffone GJ; Savory J; Killingsworth LM
    Ann Clin Lab Sci; 1976; 6(6):525-8. PubMed ID: 999222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the Optilite
    Nespola B; Comitogianni H; Jahn I; Goetz J
    Ann Biol Clin (Paris); 2019 Aug; 77(4):447-452. PubMed ID: 31339492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune complexes in schistosomiasis IV. C3, C4 and C1q characterization and correlation between C3 in serum and circulating IC levels.
    Santoro F; Bout D; Camus D; Capron A
    Rev Inst Med Trop Sao Paulo; 1977; 19(1):39-42. PubMed ID: 897474
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitation of serum complement components and plasma C3d in patients with malignant lymphoma: relation to the stage of the tumor and circulating immune complexes.
    Heier HE; Carpentier NA; Lambert PH; Godal T
    Int J Cancer; 1978 Jun; 21(6):695-9. PubMed ID: 669852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
    Sheĭtanov I; Nikolov K; Petrova P
    Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay of complement activity in human serum using large unilamellar liposomes.
    Masaki T; Okada N; Yasuda R; Okada H
    J Immunol Methods; 1989 Sep; 123(1):19-24. PubMed ID: 2794527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Measurement of serum complement hemolytic activity--effect of separation and storage conditions of the serum and reference values].
    Okumura N; Kameko M; Kanai M
    Rinsho Byori; 1983 Nov; 31(11):1219-23. PubMed ID: 6672294
    [No Abstract]   [Full Text] [Related]  

  • 11. The complement system enhances the clearance of phosphatidylserine (PS)-liposomes in rat and guinea pig.
    Huong TM; Ishida T; Harashima H; Kiwada H
    Int J Pharm; 2001 Mar; 215(1-2):197-205. PubMed ID: 11250105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
    Davis P; Cumming RH; Verrier-Jones J
    Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of urticaria and acute serum sickness with the C1q precipitin test.
    Lieberman P; Rice MC; Mallette JE
    Arch Intern Med; 1977 Apr; 137(4):440-2. PubMed ID: 139855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Components of the classical complement pathway in systemic lupus erythematosus].
    Maillet F; Goetz J; Hauptmann G; Clauvel JP; Mery JP; Kahn MF; Kazatchkine M
    Presse Med; 1987 Mar; 16(8):378-82. PubMed ID: 2950498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypocomplementemia with low C1s-C1 inhibitor complex in systemic lupus erythematosus.
    Lockshin MD; Qamar T; Redecha P; Harpel PC
    Arthritis Rheum; 1986 Dec; 29(12):1467-72. PubMed ID: 3492208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
    Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
    Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
    Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulating immune complexes and complement levels in hemophilic children.
    Verroust F; Adam C; Kourilsky O; Allain JP; Verroust P
    J Clin Lab Immunol; 1981 Sep; 6(2):127-30. PubMed ID: 6912882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement components of C3 and C4 in Nigerians.
    Olusi SO; McFarlane H
    Trop Geogr Med; 1975 Sep; 27(3):262-4. PubMed ID: 1181674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.